Citation Impact
Citing Papers
Denosumab Compared With Zoledronic Acid for the Treatment of Bone Metastases in Patients With Advanced Breast Cancer: A Randomized, Double-Blind Study
2010 Standout
Breast and Ovarian Cancer Risks Due to Inherited Mutations in BRCA1 and BRCA2
2003 StandoutScience
Transcriptional Regulation by Nrf2
2017 Standout
Breast cancer
2019 Standout
Triple-Negative Breast Cancer: Clinical Features and Patterns of Recurrence
2007 Standout
The Angelina Jolie effect: Contralateral risk-reducing mastectomy trends in patients at increased risk of breast cancer
2021
Cancer treatment and survivorship statistics, 2022
2022 Standout
Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries
2021 Standout
The DNA-damage response in human biology and disease
2009 StandoutNature
Chipping Away the ‘Missing Heritability’: GIANT Steps Forward in the Molecular Elucidation of Obesity – but Still Lots to Go
2010
BRCA1 and BRCA2: 1994 and beyond
2004
Guidelines for a genetic risk based approach to advising women with a family history of breast cancer
2000
Impact of endocrine disruptor chemicals in gynaecology
2007
Cancer Incidence in BRCA1 Mutation Carriers
2002
The risk of renal impairment in hormone‐refractory prostate cancer patients with bone metastases treated with zoledronic acid
2007
Frequency of Symptoms of Ovarian Cancer in Women Presenting to Primary Care Clinics
2004
Founder mutations in BRCA1 and BRCA2 genes
2007
Exploring the course of psychological distress around two successive control visits in women at hereditary risk of breast cancer
2005
African ancestry and higher prevalence of triple‐negative breast cancer
2010
Cell-cycle checkpoints and cancer
2004 StandoutNature
BRCA1 and BRCA2 Mutation Analysis of 208 Ashkenazi Jewish Women with Ovarian Cancer
2000
Ovarian cancer
2014 Standout
Ongoing Care of Patients After Primary Treatment for Their Cancer
2003
Genetic counseling forBRCA1/2: A randomized controlled trial of two strategies to facilitate the education and counseling process
2005
Breast cancer: occurrence, risk factors and hormone metabolism
2003
Role of surgical outcome as prognostic factor in advanced epithelial ovarian cancer: A combined exploratory analysis of 3 prospectively randomized phase 3 multicenter trials
2009 Standout
PD-1/PD-L1 and immunotherapy for pancreatic cancer
2017
Nutrition and physical activity guidelines for cancer survivors
2012 Standout
Lifestyle-related factors and environmental agents causing cancer: An overview
2007 StandoutNobel
Pancreatic cancer
2016 Standout
Blood Transfusion and Overall Quality of Life After Hip Fracture in Frail Elderly Patients—The Transfusion Requirements in Frail Elderly Randomized Controlled Trial
2015
Hereditary ovarian carcinoma: Heterogeneity, molecular genetics, pathology, and management
2009
Breast cancer risk associated with BRCA1 and BRCA2 in diverse populations
2007
An update on male breast cancer and future directions for research and treatment
2013
American Cancer Society Guidelines for Breast Screening with MRI as an Adjunct to Mammography
2007 Standout
Data Resource Profile: The Danish National Prescription Registry
2016 Standout
Tamoxifen and risk of contralateral breast cancer in BRCA1 and BRCA2 mutation carriers: a case-control study
2000
Detoxification: A Novel Function of BRCA1 in Tumor Suppression?
2011
Life’s Essential 8: Updating and Enhancing the American Heart Association’s Construct of Cardiovascular Health: A Presidential Advisory From the American Heart Association
2022 Standout
Quality of life and psychosexual adjustment after prophylactic oophorectomy for a family history of ovarian cancer
2001
Risk of second primary cancer in men with breast cancer
2007
Genetics of breast cancer: a topic in evolution
2015
Molecular mechanisms of cisplatin resistance
2011 Standout
Recommendations for Cardiovascular Health and Disease Surveillance for 2030 and Beyond: A Policy Statement From the American Heart Association
2020
Multiple primary tumors in men with breast cancer diagnoses—a SEER database review
2008
Primary breast cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
2010 Standout
Epidemiology of breast cancer: an environmental disease?Note
2001
The DNA Damage Response: Making It Safe to Play with Knives
2010 Standout
Curcumin: The story so far
2005 Standout
Personalised medicine and population health: breast and ovarian cancer
2018
The Danish National Patient Registry: a review of content, data quality, and research potential
2015 Standout
Rapamycin fed late in life extends lifespan in genetically heterogeneous mice
2009 StandoutNature
Male breast cancer
2006 Standout
Modifiers of risk of hereditary breast and ovarian cancer
2002
The Fanconi Anemia/BRCA pathway: new faces in the crowd
2005
Cancer risks among BRCA1 and BRCA2 mutation carriers
2007
On the Use of Familial Aggregation in Population-Based Case Probands for Calculating Penetrance
2002
Paclitaxel plus Bevacizumab versus Paclitaxel Alone for Metastatic Breast Cancer
2007 Standout
Update on Familial Pancreatic Cancer
2010
Oral Contraceptives and the Risk of Breast Cancer in BRCA1 and BRCA2 Mutation Carriers
2002
The Nrf2 regulatory network provides an interface between redox and intermediary metabolism
2014 Standout
Risk-Reducing Salpingo-oophorectomy in Women with aBRCA1orBRCA2Mutation
2002
Recent Advances in Breast Cancer Genetics
2007
Early breast cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
2019 Standout
Cisplatin in cancer therapy: Molecular mechanisms of action
2014 Standout
Olaparib Maintenance Therapy in Platinum-Sensitive Relapsed Ovarian Cancer
2012 Standout
Occult Cancer of the Fallopian Tube in BRCA-1 Germline Mutation Carriers at Prophylactic Oophorectomy: A Case for Recommending Hysterectomy at Surgical Prophylaxis
2001
Impact of Informing Overweight Individuals about the Role of Genetics in Obesity: An Online Experimental Study
2013 Standout
Genomic instability — an evolving hallmark of cancer
2010 Standout
Large Genomic Rearrangement in BRCA1 and BRCA2 and Clinical Characteristics of Men with Breast Cancer in the United States
2007
Bisphosphonates—much more than only drugs for bone diseases
2019
Male breast cancer
2009
Population BRCA1 and BRCA2 Mutation Frequencies and Cancer Penetrances: A Kin–Cohort Study in Ontario, Canada
2006
Fertility preservation in female patients
2004
The cancer genome
2009 StandoutNature
Cancer of the Ovary
2004 Standout
Direct-to-patient BRCA1 testing: the Twoj Styl experience
2006
Predictors of comprehensive surgical treatment in patients with ovarian cancer
2007
AASLD Practice Guidance on the clinical assessment and management of nonalcoholic fatty liver disease
2023 Standout
Riding the Crest of the Teachable Moment: Promoting Long-Term Health After the Diagnosis of Cancer
2005 Standout
The lifetime risks of breast cancer in Ashkenazi Jewish carriers of BRCA1 and BRCA2 mutations.
2001
Transfusion thresholds and other strategies for guiding allogeneic red blood cell transfusion
2016 Standout
Change in the penetrance of founder BRCA1/2 mutations? A retrospective cohort study
2002
The cBio Cancer Genomics Portal: An Open Platform for Exploring Multidimensional Cancer Genomics Data
2012 Standout
Lipid Nanoparticles Delivering Constitutively Active STING mRNA to Stimulate Antitumor Immunity
2022 StandoutNobel
Capturing Magnesium Ions via Microfluidic Hydrogel Microspheres for Promoting Cancellous Bone Regeneration
2021 Standout
Endocrine-Disrupting Chemicals: An Endocrine Society Scientific Statement
2009 Standout
American Society of Clinical Oncology Recommendations on Fertility Preservation in Cancer Patients
2006 Standout
Ovarian cancer statistics, 2018
2018 Standout
Decision aids for people facing health treatment or screening decisions
2017 Standout
Ovarian cancer risk in Ashkenazi Jewish carriers of BRCA1 and BRCA2 mutations.
2002
Weight, Weight Gain, and Survival After Breast Cancer Diagnosis
2005
International patterns and trends in ovarian cancer incidence, overall and by histologic subtype
2017
Clinical Characteristics of Individuals With Germline Mutations in BRCA1 and BRCA2: Analysis of 10,000 Individuals
2002
Breast Cancer Risk Following Bilateral Oophorectomy in BRCA1 and BRCA2 Mutation Carriers: An International Case-Control Study
2005 Standout
Fallopian Tube and Primary Peritoneal Carcinomas Associated With BRCA Mutations
2003
Screening for Founder Mutations in BRCA1 and BRCA2 in Unselected Jewish Women
2009
Clinical Characteristics of Individuals With Germline Mutations in BRCA1 and BRCA2: Analysis of 10,000 Individuals
2002
Multidisciplinary Meeting on Male Breast Cancer: Summary and Research Recommendations
2010 Standout
DNA Repair Pathways in Clinical Practice: Lessons From Pediatric Cancer Susceptibility Syndromes
2006
Modifiers of Cancer Risk in BRCA1 and BRCA2 Mutation Carriers: A Systematic Review and Meta-Analysis
2014
Obesity: global epidemiology and pathogenesis
2019 Standout
Effect of Short-Term Hormone Replacement Therapy on Breast Cancer Risk Reduction After Bilateral Prophylactic Oophorectomy in BRCA1 and BRCA2 Mutation Carriers: The PROSE Study Group
2005 Standout
Nonalcoholic fatty liver disease progression rates to cirrhosis and progression of cirrhosis to decompensation and mortality: a real world analysis of Medicare data
2020
Enzyme induction and dietary chemicals as approaches to cancer chemoprevention: the Seventh DeWitt S. Goodman Lecture.
2003
Breast cancer statistics, 2013
2013 Standout
Works of Alexander Liede being referenced
Hereditary breast and ovarian cancer in Asia: genetic epidemiology ofBRCA1 andBRCA2
2002
BRCA1 and BRCA2 mutations among breast cancer patients from the Philippines
2002
A multicenter study of supportive‐expressive group therapy for women with BRCA1/BRCA2 mutations
2004
Diminished Quality of Life and Physical Function in Community-Dwelling Elderly With Anemia
2009
A supportive-expressive group intervention for women with a family history of breast cancer: results of a phase II study
2000
Incidence of bone metastases in patients with solid tumors: analysis of oncology electronic medical records in the United States
2018
Evaluation of the needs of spouses of female carriers of mutations in BRCA1 and BRCA2
2002
Evidence of a founder BRCA1 mutation in Scotland
2000
Contribution of BRCA1 and BRCA2 Mutations to Breast and Ovarian Cancer in Pakistan
2002
Validation of algorithms to detect distant metastases in men with prostate cancer using routine registry data in Denmark
2015
Effect of Smoking on Breast Cancer in Carriers of Mutant BRCA1 or BRCA2 Genes
1998
Risk-reducing mastectomy rates in the US: a closer examination of the Angelina Jolie effect
2018
Evaluation of the Needs of Male Carriers of Mutations in BRCA1 or BRCA2 Who Have Undergone Genetic Counseling
2000
Preferences for breast cancer risk reduction among BRCA1/BRCA2 mutation carriers: a discrete-choice experiment
2017
Prevalence and Penetrance of BRCA1 and BRCA2 Gene Mutations in Unselected Ashkenazi Jewish Women With Breast Cancer
1999
Use of the Medicare database in epidemiologic and health services research: a valuable source of real-world evidence on the older and disabled populations in the US
2017
Cancer Incidence in a Population of Jewish Women at Risk of Ovarian Cancer
2002
Cancer Incidence in a Population of Jewish Women at Risk of Ovarian Cancer
2002
Cancer Risks for Male Carriers of Germline Mutations in BRCA1 or BRCA2: A Review of the Literature
2004